Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Jul 06, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-081433.pdf
0001104659-20-081433.rtf
0001104659-20-081433.xls
Jul 06, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-081435.pdf
0001104659-20-081435.rtf
0001104659-20-081435.xls
Jul 06, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-081441.pdf
0001104659-20-081441.rtf
0001104659-20-081441.xls
Jul 06, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-081442.pdf
0001104659-20-081442.rtf
0001104659-20-081442.xls
Jun 29, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-20-077691.pdf
0001104659-20-077691.rtf
0001104659-20-077691.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 17, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-074272.pdf
0001104659-20-074272.rtf
0001104659-20-074272.xls
Jun 01, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-20-068477.pdf
0001104659-20-068477.rtf
0001104659-20-068477.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 01, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-068529.pdf
0001104659-20-068529.rtf
0001104659-20-068529.xls
Jun 01, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-068530.pdf
0001104659-20-068530.rtf
0001104659-20-068530.xls
Jun 01, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-068535.pdf
0001104659-20-068535.rtf
0001104659-20-068535.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
10 Hudson Yards, 37th Floor|New York, NY 10001|T: 844-782-ICPT
© 2020 Intercept Pharmaceuticals, Inc.